A thrombotic complication of COVID-19: cerebral ischaemia in the intensive care unit

Abstract

COVID-19 may predispose to thromboembolic disease due to severe inflammation, hypoxia, and immobilisation [1]. The severe hypercoagulable state of COVID-19 patients includes systemic micro- and macrovascular thrombosis. Anticoagulant therapy, mainly with low-molecular-weight heparin, appears to be associated with better prognosis in severe COVID-19 patients [2].